Literature DB >> 11167315

Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

J Spijker1, R V Bijl, R de Graaf, W A Nolen.   

Abstract

OBJECTIVE: To investigate risk factors of poor 1-year outcome of major depression in the general population and to compare the results with data from clinical populations.
METHOD: Psychiatric diagnoses were determined in a representative sample (N = 7,076) of the Dutch general population, using the Composite International Diagnostic Interview (CIDI) at baseline and 12 months later. A broad range of potential risk factors were evaluated.
RESULTS: Of the depressed people at baseline, 28.3% were depressed 12 months later. Younger age, severity of depression, longer duration of previous episodes, the presence of anhedonia and early awakening, external locus of control and multiple negative life events appear to be risk factors.
CONCLUSION: Poor outcome of major depression is frequent in the general population. Largely the same risk factors are involved as in clinical populations.

Entities:  

Mesh:

Year:  2001        PMID: 11167315     DOI: 10.1034/j.1600-0447.2001.103002122.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  84 in total

Review 1.  The effects of life events and social relationships on the course of major depression.

Authors:  Traolach S Brugha
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

Review 2.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

3.  The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods.

Authors:  Ron de Graaf; Margreet Ten Have; Saskia van Dorsselaer
Journal:  Int J Methods Psychiatr Res       Date:  2010-09       Impact factor: 4.035

4.  Alcohol Use Disorder and the Persistence/Recurrence of Major Depression: Le trouble de l'usage de l'alcool et la persistance/récurrence de la dépression majeure.

Authors:  Vivian N Onaemo; Timothy O Fawehinmi; Carl D'Arcy
Journal:  Can J Psychiatry       Date:  2020-05-04       Impact factor: 4.356

5.  Anhedonia modulates the effects of positive mood induction on reward-related brain activation.

Authors:  Isobel W Green; Diego A Pizzagalli; Roee Admon; Poornima Kumar
Journal:  Neuroimage       Date:  2019-03-01       Impact factor: 6.556

6.  Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach.

Authors:  Verena Enneking; Pia Krüssel; Dario Zaremba; Katharina Dohm; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Christian Bürger; Fanni Dzvonyar; Elisabeth J Leehr; Joscha Böhnlein; Jonathan Repple; Nils Opel; Nils R Winter; Tim Hahn; Ronny Redlich; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

7.  Reduced reward learning predicts outcome in major depressive disorder.

Authors:  Elske Vrieze; Diego A Pizzagalli; Koen Demyttenaere; Titia Hompes; Pascal Sienaert; Peter de Boer; Mark Schmidt; Stephan Claes
Journal:  Biol Psychiatry       Date:  2012-12-08       Impact factor: 13.382

Review 8.  The promise of ketamine for treatment-resistant depression: current evidence and future directions.

Authors:  Kaitlin E DeWilde; Cara F Levitch; James W Murrough; Sanjay J Mathew; Dan V Iosifescu
Journal:  Ann N Y Acad Sci       Date:  2015-02-03       Impact factor: 5.691

9.  The course of untreated anxiety and depression, and determinants of poor one-year outcome: a one-year cohort study.

Authors:  Ilse Mj van Beljouw; Peter Fm Verhaak; Pim Cuijpers; Harm Wj van Marwijk; Brenda Wjh Penninx
Journal:  BMC Psychiatry       Date:  2010-10-20       Impact factor: 3.630

10.  Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans.

Authors:  Daniel G Dillon; Ryan Bogdan; Jesen Fagerness; Avram J Holmes; Roy H Perlis; Diego A Pizzagalli
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.